Why us?
We are an internationally accredited medical center with seven medical licenses, oversight by eight board certifications and committees, and board certified health professionals and scientists dedicating their careers to the research of regenerative medicine and its effects on chronic degenerative conditions.
Stem cell regulations
We adhere and comply with the best clinical trial practices and also adopt the best international practices to offer a safe experience. Our Clinic adheres to the laws and licenses of the corresponding Mexican regulatory agency COFEPRIS they are the health bureau in Mexico in charge of regulating and expediting licenses, and monitoring good medical practices.
Mexican and FDA registered clinical trial protocols
- Knee Osteoarthritis
- Chronic Musculoskeletal Pain
- Spinal Cord Injury
Accreditations
The Global Healthcare Accreditation® (GHA) Program is an independent accrediting body that seeks to improve the patient experience and excellence of care received by patients who travel for their medical care and treatment, whether within their own country or internationally. Novastem is the only clinic in Mexico, and the only Stem-Cell clinic in the world with such honor.
Accredited in 2017
HOW WE WORK?
SAFE CELLS
We use cells produced by the most experienced cellular manufacturers in the world. We prioritize safety and engage all of our patients in an open and transparent risk-benefit analysis.
SECURITY
We not only utilize cGMP certified manufacturers to provide our stem cells, but we also perform regular QA audits to make sure that all products are safe for injection.
SPECIALIZED TEAM
Our medical staff is comprised of world-class physicians and scientists with decades of experience in regenerative medicine.
The Novastem Diference
Led by a team of world-class physicians and scientists, Novastem has created a unique stem cell clinic. With access to best-in-class anufacturers and personalized cell sourcing strategies, we will provide your best option for effective therapies. With a commitment to patient safety and a realistic risk-benefit analysis.
ES 
EN_US